Sleep apnea is common in patients with coronary artery disease
Christian Prinz1, Thomas Bitter, Cornelia Piper
1Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany, akleemeyer@hdz-nrw.de.
Insights
Sleep-disordered breathing (SDB) is common in coronary artery disease (CAD) patients and linked to higher inflammation markers. This suggests SDB may worsen CAD progression or trigger acute cardiac events.
Area of Science:
- Cardiology
- Sleep Medicine
- Inflammation Research
Background:
- Sleep-disordered breathing (SDB) is a known factor impacting cardiac disease prognosis.
- Coronary artery disease (CAD) patients often have undiagnosed sleep issues.
- Chronic inflammation plays a role in the development and progression of CAD.
Purpose of the Study:
- To investigate the prevalence of SDB in patients with established CAD and preserved left ventricular function.
- To explore the association between SDB, systemic inflammation markers (hs-CRP, fibrinogen), and CAD.
- To determine if SDB severity correlates with inflammatory markers in this patient group.
Main Methods:
- Cardiorespiratory polygraphy was used to diagnose SDB in 257 CAD patients.
- High-sensitivity C-reactive protein (hs-CRP) and fibrinogen levels were measured in 251 patients.
- Patients were categorized based on SDB presence, type (central/obstructive), and hs-CRP levels.
Main Results:
- SDB was prevalent in 188 (73%) of the CAD patients studied.
- Patients with SDB exhibited significantly higher fibrinogen levels compared to those without SDB (p=0.01).
- Higher hs-CRP levels (>0.5 mg/dl) were associated with significantly more severe SDB (p=0.01).
Conclusions:
- SDB is highly prevalent in patients with coronary artery disease.
- SDB in CAD patients is associated with elevated markers of chronic inflammation.
- These findings suggest a potential link between SDB, inflammation, and CAD progression or acute coronary events.
Abstract:
Sleep-disordered breathing (SDB) has a prognostic impact in patients with cardiac diseases. We included 257 patients with preserved left ventricular function and angiographically proven coronary artery disease (CAD). All patients underwent cardiorespiratory polygraphy. In 251 patients high-sensitive C-reactive protein and fibrinogen were measured. SDB was documented in 188 patients (apnea-hypopnea-index [AHI] 16.4+/- 1.9/h): 58 patients presented central sleep apnea (CSA) and 130 patients obstructive sleep apnea (OSA). All patients (73%) with SDB had higher blood fibrinogen levels than those without SDB (p = 0.01). We found 197 patients with CRP-values below the cut-off of 0.5 mg/dl (group 1) and 54 patients with no active infection but CRP>0.5 mg/dl (group 2). Severity of SDB was significantly higher in group 2 (p = 0.01). SDB has a high prevalence in CAD patients and seems to be associated with chronic inflammation, which may be linked to CAD progression and/or acute coronary events.
More Related Videos
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
